Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2024JCI InsightOpen Access

Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJocelyn CervantesJKJuraj KoskaFKFarah Kramer

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cervantes et al. (2024) studied this question.

synapsesocial.com/papers/68e6a28cb6db6435876263b4https://doi.org/10.1172/jci.insight.177268
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetes2025 · 3 citations
  2. 22682-P: Targeting APOC3 Preserves β-Cell Function in a Mouse Model of Type 2 Diabetes2026
  3. 3Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics2015 · 80 citations
  4. 4Apolipoprotein CIII and diabetes. Is there a link?2018 · 21 citations
  5. 5Targeting accumulated apolipoprotein J in renal tubules halts the mTOR-TFEB interaction and relieves diabetic kidney disease2024 · 1 citations